Mentice AB (STO: MNTC) announces that the company will present its Q2 2025 Interim Report for the period April–June via a webcast conference call on Thursday, July 24, 2025, at 10:00 CEST.

The webcast will feature presentations from CEO Frans Venker and CFO Ulrika Drotz, who will share key insights into the company’s financial results and strategic progress. The session will conclude with a live Q&A, moderated by Rikard Engberg, Analyst at Carnegie.

The presentation will be conducted in English, and participants are encouraged to register in advance.

For registration details and access to the webcast, please visit https://investor.mentice.com/.

‍

For more information, please contact:
Stacy Hammar, Marketing Director, Mentice
E-post: stacy.hammar@mentice.com
Mobile: +46 732 345 285

‍

About Mentice
Mentice (STO: MNTC) is the world leader in proficiency based simulation solutions for image guided interventional therapies. Our solutions help healthcare professionals acquire, retain, and enhance their procedural skills driving improved productivity and outcomes. Mentice solutions are scientifically validated and have been specifically developed for healthcare providers and the medical device industry. Neurovascular, cardiovascular, and peripheral interventions are just some of the clinical areas covered by our solutions. Learn more about the features and benefits of Mentice solutions at: www.mentice.com

Marketplace| Nasdaq First North Growth Market, Stockholm | Ticker symbol MNTC
Certified Adviser| FNCA Sweden AB